The closest performing GLP-1 medicine in terms of average weight loss is Novo Nordisks CagriSema, an Amylin/GLP-1 dual agonist, which had an average weight loss of 22.7% after 68 weeks in Phase 3 trials
What is included in the price Your monthly payment covers several things beyond just the medication: Licensed provider review and ongoing oversight Compounded semaglutide medication Free dietitian access (included at no extra cost) Patient portal with tracking for injections, symptoms, and progress Nursing support by phone and text during business hours Shipping (often overnight after label creation) The inclusion of a free dietitian is notable
CareCredit financing is available
Animal studies in diet-induced obesity models show tesofensine treatment produces selective reduction in adiposity with improvements in insulin sensitivity, reductions in plasma lipids, and decreased accumulation of abdominal and subcutaneous fat mass
Atrial fibrillation occurs when the top chambers of your heart quiver or twitch, with the heart beating faster than normal, and it often beats irregularly without a constant pattern
Potential Risks : Off-label use can pose risks, such as unexpected side effects
